ABBOTT LABORATORIES Operating Cash Flow 2007-2026 | ABT
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is ABBOTT LABORATORIES's current operating cash flow?
ABBOTT LABORATORIES (ABT) annual operating cash flow for 2025 was $9.57B, a 11.78% increase from 2024. ABBOTT LABORATORIES operating cash flow for the quarter ending March 31, 2026 was $1.31B.
What was ABBOTT LABORATORIES's operating cash flow in 2024?
ABBOTT LABORATORIES annual operating cash flow for 2024 was $8.56B, a 17.86% increase from 2023.
What was ABBOTT LABORATORIES's operating cash flow in 2023?
ABBOTT LABORATORIES annual operating cash flow for 2023 was $7.26B, a 24.21% decline from 2022.
What is ABBOTT LABORATORIES's 5-year operating cash flow CAGR?
ABBOTT LABORATORIES operating cash flow grew at a compound annual growth rate (CAGR) of 3.90% from FY2020 to FY2025, going from $7.90B to $9.57B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.57B | +11.8% | 10-K |
| FY2024 | $8.56B | +17.9% | 10-K |
| FY2023 | $7.26B | -24.2% | 10-K |
| FY2022 | $9.58B | -9.0% | 10-K |
| FY2021 | $10.53B | +33.3% | 10-K |
| FY2020 | $7.90B | +28.8% | 10-K |
| FY2019 | $6.14B | -2.6% | 10-K |
| FY2018 | $6.30B | +13.1% | 10-K |
| FY2017 | $5.57B | +73.9% | 10-K |
| FY2016 | $3.20B | +8.0% | 10-K |
| FY2015 | $2.97B | -19.3% | 10-K |
| FY2014 | $3.67B | +10.6% | 10-K |
| FY2013 | $3.32B | -64.3% | 10-K |
| FY2012 | $9.31B | +3.8% | 10-K |
| FY2011 | $8.97B | +2.7% | 10-K |
| FY2010 | $8.74B | +20.1% | 10-K |
| FY2009 | $7.28B | +4.0% | 10-K |
| FY2008 | $6.99B | +34.9% | 10-K |
| FY2007 | $5.18B | - | 10-K |